Osborn B. Eden

2.2k total citations
26 papers, 1.6k citations indexed

About

Osborn B. Eden is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Osborn B. Eden has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Public Health, Environmental and Occupational Health and 7 papers in Hematology. Recurrent topics in Osborn B. Eden's work include Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (6 papers) and DNA Repair Mechanisms (4 papers). Osborn B. Eden is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (6 papers) and DNA Repair Mechanisms (4 papers). Osborn B. Eden collaborates with scholars based in United Kingdom, Germany and United States. Osborn B. Eden's co-authors include Mel Greaves, Anthony M. Ford, Jillian M. Birch, Richard McNally, Claudia Isabelle Keller Valsecchi, Reinald Repp, Arndt Borkhardt, Karin B. Gale, Anna Kelsey and G. Malcolm Taylor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer.

In The Last Decade

Osborn B. Eden

26 papers receiving 1.5k citations

Peers

Countries citing papers authored by Osborn B. Eden

Since Specialization

Citations

This map shows the geographic impact of Osborn B. Eden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osborn B. Eden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osborn B. Eden more than expected).

Fields of papers citing papers by Osborn B. Eden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osborn B. Eden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osborn B. Eden. The network helps show where Osborn B. Eden may publish in the future.

Co-authorship network of co-authors of Osborn B. Eden

This figure shows the co-authorship network connecting the top 25 collaborators of Osborn B. Eden. A scholar is included among the top collaborators of Osborn B. Eden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osborn B. Eden. Osborn B. Eden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rhabdomyosarcoma in Nijmegen breakage syndrome: strong association with perianal primary site 2004 ·Cancer Genetics and Cytogenetics ·Stefan Meyer, Helen Kingston, A. Malcolm R. Taylor, (unknown), James I. Last, Bernadette Brennan, (unknown), Anna Kelsey, Geoffrey Taylor, Osborn B. Eden	29
2	Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia 2003 ·British Journal of Haematology ·(unknown), Helen E. McGrath, Stefan Meyer, Andrew Will, Jillian M. Birch, Osborn B. Eden, G. Malcolm Taylor	15
3	Geographical and ecological analyses of childhood acute leukaemias and lymphomas in north‐west England 2003 ·British Journal of Haematology ·Richard McNally, Richard Alston, (unknown), Osborn B. Eden, Jillian M. Birch	32
4	Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk‐stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172) 2003 ·British Journal of Haematology ·Frank G. H. Hill, Sue Richards, Brenda Gibson, Ian Hann, John Lilleyman, Sally E. Kinsey, Christopher Mitchell, Christine J. Harrison, Osborn B. Eden	59
5	Geographical and ecological analyses of childhood Wilms’ tumours and soft-tissue sarcomas in North West England 2003 ·European Journal of Cancer ·Richard McNally, Richard Alston, (unknown), Osborn B. Eden, Anna Kelsey, Jillian M. Birch	17
6	Space‐time clustering patterns in childhood solid tumours other than central nervous system tumours 2002 ·International Journal of Cancer ·Richard McNally, Anna Kelsey, Osborn B. Eden, Freda E. Alexander, (unknown), Jillian M. Birch	20
7	Relative frequency and morphology of cancers in carriers of germline TP53 mutations 2001 ·Oncogene ·Jillian M. Birch, Richard Alston, Richard McNally, D. Gareth Evans, Anna Kelsey, Martin Harris, Osborn B. Eden, Jennifer M. Varley	313
8	Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol 2001 ·British Journal of Haematology ·Ian Hann, Ajay Vora, G Harrison, Christine J. Harrison, Osborn B. Eden, Frank G. H. Hill, Brenda Gibson, Sue Richards	99
9	Temporal increases in the incidence of childhood solid tumors seen in Northwest England (1954–1998) are likely to be real 2001 ·Cancer ·Richard McNally, Anna Kelsey, (unknown), G. Malcolm Taylor, Osborn B. Eden, Jillian M. Birch	55
10	Molecular tracking of leukemogenesis in a triplet pregnancy 2001 ·Blood ·Ana-Teresa Maia, Anthony M. Ford, G. Reza Jalali, Christine J. Harrison, G M Taylor, Osborn B. Eden, Mel Greaves	74
11	SECONDARY LEUKEMIA IN A CHILD WITH NEUROBLASTOMA WHILE ON ORAL ETOPOSIDE: What is the Cause? 2000 ·Pediatric Hematology and Oncology ·(unknown), G. Malcolm Taylor, Osborn B. Eden	9
12	Leptomeningeal melanoma in childhood 1999 ·Cancer ·Guy Makin, Osborn B. Eden, L. S. Lashford, John Moppett, Mary Gerrard, Helena Davies, Colin Powell, (unknown), (unknown)	59
13	Leptomeningeal melanoma in childhood 1999 ·Cancer ·Guy Makin, Osborn B. Eden, L. S. Lashford, John Moppett, Mary Gerrard, Helena Davies, Colin Powell, (unknown), (unknown)	2
14	Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro 1998 ·Cancer Chemotherapy and Pharmacology ·Helen Robson, Elizabeth J. Anderson, Osborn B. Eden, Olle Isaksson, Stephen Shalet	11
15	Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots 1997 ·Proceedings of the National Academy of Sciences ·Karin B. Gale, Anthony M. Ford, Reinald Repp, Arndt Borkhardt, Claudia Isabelle Keller Valsecchi, Osborn B. Eden, Mel Greaves	405
16	Increased radiosensitivity in a child with T-cell non-Hodgkin's lymphoma 1996 ·Medical and Pediatric Oncology ·Simon Attard-Montalto, Vaskar Saha, Judith Kingston, Nicholas Plowman, A. Malcolm R. Taylor, C.F. Arlett, B.A. Bridges, Osborn B. Eden	4
17	A Pharmacokinetic Study of Sublingual Aerosolized Morphine in Healthy Volunteers 1996 ·Journal of Pharmacy and Pharmacology ·(unknown), Kevin Taylor, Simon P. Joel, M L Slevin, Osborn B. Eden	7
18	Ewing's sarcoma in a child with human immunodeficiency virus (type 1) infection 1993 ·Medical and Pediatric Oncology ·E. G. Hermione Lyall, (unknown), Osborn B. Eden, Jacqueline Mok, Nicholas M. Croft	9
19	ASSESSMENT OF A CLINICAL SCORING SYSTEM FOR DETECTION OF IMMUNODEFICIENCY IN CHILDREN WITH RECURRENT INFECTIONS 1991 ·The Pediatric Infectious Disease Journal ·E. G. Hermione Lyall, Osborn B. Eden, Robert Dixon, Ronald S. Sutherland, Anne Thomson	5
20	Possible Interferon Response in a Child with Measles Encephalitis during Immunosuppression 1984 ·Scandinavian Journal of Infectious Diseases ·(unknown), Osborn B. Eden	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact